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Objectives.Theobjectiveofthisstudywastodeterminewhetherthereisarelationshipbetweendepressionandriskofhepatocellular
carcinoma(HCC)inolderpeopleinTaiwan.Methods.Acase-controlstudywasconductedtoanalyzethedatabasefromtheTaiwan
National Health Insurance program. We selected 1815 subjects aged 65 years or older with newly diagnosed HCC as the case group
and 7260 subjects without HCC as the comparison group, from 2000 to 2010. Both groups were compared to measure the risk
of HCC. Results. After controlling for confounders, the odds ratio of HCC was 0.81 in subjects with depression (95% confidence
interval = 0.59, 1.11), as compared with nondepressed subjects. Conclusions. We conclude that no association is detected between
depression and risk of hepatocellular carcinoma in older people in Taiwan.
1. Introduction
Until now, controversies exist regarding the relationship
betweendepressionandsubsequentcancerrisk.Thatis,some
s t u d i e ss h o w e da ni n c r e a s e dr i s k[ 1, 2], but others showed
no increased risk [3, 4]. Similarly, no specific evidence is
available about the relationship between depression and risk
of hepatocellular carcinoma (HCC) in older people. In order
to explore this issue, a population-based case-control study
was conducted to analyze the database from the Taiwan
National Health Insurance program.
2. Methods
ThedetailsoftheTaiwanNationalHealthInsuranceprogram
c a nb ed o c u m e n t e di np r e v i o u ss t u d i e s[ 5–7]. In this case-
c o n t r o ls t u d y ,w er a n d o m l ys e l e c t e d1 8 1 5s u b j e c t sa g e d6 5
y e a r so ro l d e rw i t hn e w l yd i a g n o s e dH C Ca st h ec a s e
group (1132 men and 683 women, mean age 74.31 years, and
standarddeviation6.29years)(accordingtotheInternational
ClassificationofDiseases9thRevision-ClinicalModification,
ICD-9 codes 155, 155.0, and 155.2) and 7260 subjects without
HCC as the comparison group (4528 men and 2732 women,
mean age 74.09 years, and standard deviation 6.53 years).
Both groups were matched with sex, age, and index year of
diagnosing HCC, from 2000 to 2010. The index date was
definedasthedateofdiagnosingHCC.Inordertoreducethe
confounding effects, subjects with any cancer (ICD-9 codes
140–208), major psychiatric diseases (ICD-9 codes 291–293,
294.0, 294.8-294.9, 295, 296.0-296.1, 296.4–296.9, and 297-
298), other dementia (290.0–290.4, and 294.1), or mental
retardation(ICD-9codes317–319)diagnosedbeforetheindex
date were excluded. Depression (ICD-9 codes 331.0) and
other comorbidities potentially associated with HCC were
diagnosed before the index date [7].2 ISRN Psychiatry
Table 1: Characteristics between hepatocellular carcinoma group and comparison group.
Hepatocellular carcinoma
P value No Yes
𝑁 =7 2 6 0 𝑁 =1 8 1 5
𝑛 (%) 𝑛 (%)
Age group (year)
65–74 4260 58.68 1065 58.68 0.99
75–84 3000 41.32 750 41.32
Sex
Men 4528 62.37 1132 62.37 0.99
Women 2732 37.63 683 37.63
Comorbidities before index date
∗
Depression 385 5.30 114 6.28 0.10
Diabetes mellitus 1941 26.74 636 35.04 <0.0001
Cirrhosis 137 1.89 990 54.56 <0.0001
Other chronic hepatitis 1163 16.02 1033 56.91 <0.0001
Hepatitis B infection 112 1.54 361 19.89 <0.0001
Hepatitis C infection 135 1.86 600 33.06 <0.0001
Alcoholism 57 0.79 24 1.32 0.03
Data are presented as the number of subjects in each group, with percentages given in parentheses.
Chi-square test comparing subjects with and without hepatocellular carcinoma.
∗Comorbiditiesincludedbeforeindexdatewereasfollows:depression(ICD-9codes296.2-296.3,300.4,and311),diabetesmellitus(ICD-9codes250),cirrhosis
(ICD-9 codes 571.2, and 571.5-571.6), other chronic hepatitis (ICD-9 codes 571.40-571.41, 571.49, and 571.8-571.9), hepatitis B infection (ICD-9 codes V02.61,
070.20, 070.22, 070.30, and 070.32), hepatitis C infection (ICD-9 codes V02.62, 070.41, 070.44, 070.51, and 070.54), and alcoholism (ICD-9 codes 303, 305.00,
305.01, 305.02, 305.03, and V11.3).
Table 2: Odds ratio and 95% confidence interval of hepatocellular carcinoma associated with depression and other comorbidities.
Variable Crude Adjusted
†
OR (95% CI) OR (95% CI)
Age (per one year) 1.01 (1.00, 1.01) 1.04 (1.03, 1.05)
Comorbidities before index date (yes versus no)
Depression 1.20 (0.97, 1.49) 0.81 (0.59, 1.11)
Diabetes mellitus 1.48 (1.33, 1.65) 1.04 (0.89, 1.22)
Cirrhosis 62.39 (51.46, 75.65) 28.55 (23.17, 35.19)
Other chronic hepatitis 6.93 (6.19, 7.75) 2.23 (1.89, 2.63)
Hepatitis B infection 15.84 (12.72, 19.73) 5.87 (4.40, 7.84)
Hepatitis C infection 26.06 (21.42, 31.72) 7.72 (6.00, 9.93)
Alcoholism 1.70 (1.05, 2.74) 0.85 (0.43, 1.68)
†Adjusted for age, diabetes mellitus, cirrhosis, other chronic hepatitis, hepatitis B infection, hepatitis C infection, and alcoholism.
3. Results
We compared the basic characteristics and co-morbidities
between the HCC group and the comparison group. Table 1
s h o w st h a tt h eH C Cg r o u pw a sm o r el i k e l yt oh a v ed i a b e t e s
mellitus, cirrhosis, other chronic hepatitis, hepatitis B infec-
tion, hepatitis C infection, and alcoholism, with statistical
significance. There were 114 subjects with depression among
the HCC group (6.28%) and 385 subjects with depression
among the comparison group (5.30%), without significant
difference (𝑃 = 0.10). After controlling for confounding fac-
tors, multivariable logistic regression analysis demonstrated
that the odds ratio (OR) of HCC was 0.81 in subjects with
depression (95% confidence interval (CI) = 0.59, 1.11), as
compared with nondepressed subjects (Table 2).
4. Discussion
To date, there is no consensus about the association between
depression and subsequent cancer risk [1–4]. One cohort
s t u d yb yC h e na n dL i ni nT a i w a ns h o w e dt h a tp a t i e n t s
with depression correlate with 1.8-fold increased risk of
gastrointestinal cancer (95% CI = 1.03, 3.14), but HCC is not
mentioned specifically [2]. In the present study, despite the
fact that we controlled the comorbidities potentially associ-
atedwithHCC,noassociationisdetectedbetweendepressionISRN Psychiatry 3
andHCCriskinolderpeople(OR=0.81,95%CI=0.59,1.11).
Generallyspeaking,70–90%ofallHCCcasesaresignificantly
associated with cirrhosis or other chronic the liver diseases
worldwide [8]. Depression is a mood disorder, not causing
chronic inflammation of liver. Therefore, these two diseases
should have their unique pathogenesis without potential
linking. Since formal depression diagnostic procedures were
not recorded in this database, more prospective studies are
necessary to validate our findings.
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